Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.041 0.2
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.046 0.2
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.1 0.2
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.066 0.2
mRNA lapatinib UHNBreast pan-cancer AAC 0.36 0.2
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.045 0.2
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA avicin D CTRPv2 pan-cancer AAC -0.067 0.2
mRNA staurosporine CTRPv2 pan-cancer AAC -0.095 0.2
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.044 0.2
Download CSV